These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33176459)

  • 21. Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians.
    Williams CP; Miller-Sonet E; Nipp RD; Kamal AH; Love S; Rocque GB
    Cancer; 2020 Aug; 126(15):3534-3541. PubMed ID: 32426870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding patients' and doctors' attitudes about shared decision making for advance care planning.
    Hajizadeh N; Uhler LM; Pérez Figueroa RE
    Health Expect; 2015 Dec; 18(6):2054-65. PubMed ID: 25336141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.
    Sangaralingham LR; Sangaralingham SJ; Shah ND; Yao X; Dunlay SM
    Circ Heart Fail; 2018 Feb; 11(2):e004302. PubMed ID: 29453287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Can I come off the tablets now?' A qualitative analysis of heart failure patients' understanding of their medication.
    Field K; Ziebland S; McPherson A; Lehman R
    Fam Pract; 2006 Dec; 23(6):624-30. PubMed ID: 16837480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of cost discussions between patients with cancer and oncologists.
    Zafar SY; Chino F; Ubel PA; Rushing C; Samsa G; Altomare I; Nicolla J; Schrag D; Tulsky JA; Abernethy AP; Peppercorn JM
    Am J Manag Care; 2015 Sep; 21(9):607-15. PubMed ID: 26618364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sacubitril/Valsartan: The Newest Addition to the Toolbox for Guideline-Directed Medical Therapy of Heart Failure.
    Rodgers JE
    Am J Med; 2017 Jun; 130(6):635-639. PubMed ID: 28285069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sacubitril-Valsartan for the Treatment of Heart Failure: Effectiveness and Value.
    Ollendorf DA; Sandhu AT; Pearson SD
    JAMA Intern Med; 2016 Feb; 176(2):249-50. PubMed ID: 26720832
    [No Abstract]   [Full Text] [Related]  

  • 28. Explorative observational study of Dutch patient-clinician interactions: operationalisation of personal perspective elicitation as part of shared decision-making in real-life audio-recorded consultations.
    Rake EA; Meinders MJ; Brand G; Dreesens D; Kremer JAM; Elwyn G; Aarts JWM
    BMJ Open; 2024 May; 14(5):e079540. PubMed ID: 38760032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Workflow Requirements for Cost-of-Care Conversations in Outpatient Settings Providing Oncology or Primary Care: A Qualitative, Human-Centered Design Study.
    Henrikson NB; Banegas MP; Tuzzio L; Lim C; Schneider JL; Walsh-Bailey C; Scrol A; Hodge SM
    Ann Intern Med; 2019 May; 170(9_Suppl):S70-S78. PubMed ID: 31060061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of sacubitril/valsartan for the treatment of patients with heart failure with reduced ejection fraction in Portugal.
    Borges M; Afonso-Silva M; Laires PA; Gouveia M; Alarcão J; Ascenção R; Costa J
    Expert Rev Pharmacoecon Outcomes Res; 2020 Apr; 20(2):199-205. PubMed ID: 31219361
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-Effectiveness of Switching Patients With Heart Failure and Reduced Ejection Fraction to Sacubitril/Valsartan: The Australian Perspective.
    Chin KL; Zomer E; Wang BH; Liew D
    Heart Lung Circ; 2020 Sep; 29(9):1310-1317. PubMed ID: 32303468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
    Hubers SA; Brown NJ
    Circulation; 2016 Mar; 133(11):1115-24. PubMed ID: 26976916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding patients' attitudes toward communication about the cost of cancer care.
    Bullock AJ; Hofstatter EW; Yushak ML; Buss MK
    J Oncol Pract; 2012 Jul; 8(4):e50-8. PubMed ID: 23180999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults.
    Hess PL; Matlock DD; Al-Khatib SM
    Clin Cardiol; 2020 Feb; 43(2):187-195. PubMed ID: 31867773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin Receptor Neprilysin Inhibitor for Patients With Heart Failure and Reduced Ejection Fraction: Real-World Experience From Taiwan.
    Hsiao FC; Wang CL; Chang PC; Lu YY; Huang CY; Chu PH
    J Cardiovasc Pharmacol Ther; 2020 Mar; 25(2):152-157. PubMed ID: 31514513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction.
    Ademi Z; Pfeil AM; Hancock E; Trueman D; Haroun RH; Deschaseaux C; Schwenkglenks M
    Swiss Med Wkly; 2017; 147():w14533. PubMed ID: 29185253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin Receptor Neprilysin Inhibitors-2019 Update.
    Chalikias G; Tziakas D
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):707-722. PubMed ID: 32519065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Talking About the Cost of Care: A Critical Component of Shared Decision Making: Patient and Provider Perspectives.
    Darien G; Wilson C; Balch A; Rebekah Angove
    J Natl Med Assoc; 2020 Apr; 112(2):225-228. PubMed ID: 32278479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure.
    Sumarsono A; Vaduganathan M; Ajufo E; Navar AM; Fonarow GC; Das SR; Pandey A
    JAMA Cardiol; 2020 Mar; 5(3):336-339. PubMed ID: 31738371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States.
    DeVore AD; Hill CL; Thomas L; Sharma PP; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; McCague K; Hernandez AF; Fonarow GC
    Circ Heart Fail; 2018 Sep; 11(9):e005400. PubMed ID: 30354360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.